APA (7th ed.) Citation

JR, I., RL, K., LS, R., P, L., SS, D., J, Z., . . . RK, R. (2018). Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumours. British journal of cancer, 118(2), 153. https://doi.org/10.1038/bjc.2017.327

Chicago Style (17th ed.) Citation

JR, Infante, et al. "Phase 1 Trials of PEGylated Recombinant Human Hyaluronidase PH20 in Patients with Advanced Solid Tumours." British Journal of Cancer 118, no. 2 (2018): 153. https://doi.org/10.1038/bjc.2017.327.

MLA (9th ed.) Citation

JR, Infante, et al. "Phase 1 Trials of PEGylated Recombinant Human Hyaluronidase PH20 in Patients with Advanced Solid Tumours." British Journal of Cancer, vol. 118, no. 2, 2018, p. 153, https://doi.org/10.1038/bjc.2017.327.